Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

Clinical trial NCT05300958 · TERMINATED

Trial details

NCT number: NCT05300958
Sponsor: Sun Yat-sen University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2022-03-21
Primary completion: 2025-07-21
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.